Evidence map›Paper›PMID 25197643›Full record

ArticleBioMed research international2014

Implementation of a computerized decision support system to improve the appropriateness of antibiotic therapy using local microbiologic data.

Manuel Rodriguez-Maresca, Antonio Sorlozano, Magnolia Grau, Rocio Rodriguez-Castaño, Andres Ruiz-Valverde, Jose Gutierrez-Fernandez

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Effectiveness of Electronic Guidelines (GERHAntibiotics (Basel, Switzerland) · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manuel Rodriguez-MarescaDepartment of Microbiology, Torrecardenas Hospital Complex, Hermandad de Donantes de Sangre s/n, 04009 Almeria, Spain.
Antonio SorlozanoDepartment of Microbiology, School of Medicine, University of Granada, Avenida de Madrid 11, 18012 Granada, Spain.
Magnolia GrauDepartment of Microbiology, Torrecardenas Hospital Complex, Hermandad de Donantes de Sangre s/n, 04009 Almeria, Spain.
Rocio Rodriguez-CastañoIntensive Care Unit, Torrecardenas Hospital Complex, Hermandad de Donantes de Sangre s/n, 04009 Almeria, Spain.
Andres Ruiz-ValverdeIntensive Care Unit, Torrecardenas Hospital Complex, Hermandad de Donantes de Sangre s/n, 04009 Almeria, Spain.
Jose Gutierrez-FernandezDepartment of Microbiology, School of Medicine, University of Granada, Avenida de Madrid 11, 18012 Granada, Spain ; Service of Microbiology, Virgen de las Nieves University Hospital, Avenida de las Fuerzas Armadas 2, 18014 Granada, Spain.
Complejo Hospitalario Torrecárdenas · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A prospective quasi-experimental study was undertaken in 218 patients with suspicion of nosocomial infection hospitalized in a polyvalent ICU where a new electronic device (GERB) has been designed for antibiotic prescriptions. Two GERB-based applications were developed to provide local resistance maps (LRMs) and preliminary microbiological reports with therapeutic recommendation (PMRTRs). Both applications used the data in the Laboratory Information System of the Microbiology Department to report on the optimal empiric therapeutic option, based on the most likely susceptibility profile of the microorganisms potentially responsible for infection in patients and taking into account the local epidemiology of the hospital department/unit. LRMs were used for antibiotic prescription in 20.2% of the patients and PMRTRs in 78.2%, and active antibiotics against the finally identified bacteria were prescribed in 80.0% of the former group and 82.4% of the latter. When neither LMRs nor PMRTRs were considered for empiric treatment prescription, only around 40% of the antibiotics prescribed were active. Hence, the percentage appropriateness of the empiric antibiotic treatments was significantly higher when LRM or PMRTR guidelines were followed rather than other criteria. LRMs and PMRTRs applications are dynamic, highly accessible, and readily interpreted instruments that contribute to the appropriateness of empiric antibiotic treatments.

Indexed as

Decision Support Systems, ClinicalHealth Plan ImplementationAnti-Bacterial AgentsBacteriaCross InfectionDrug Resistance, BacterialElectronics, MedicalFemaleHealth Planning GuidelinesHumansLength of StayMalePrescription DrugsAnti-Bacterial AgentsPrescription Drugs

Identifiers

PMID25197643
PMCPMC4150543
OpenAlexW2159407000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.